Shanghai Bao Pharmaceuticals Co., Ltd. (HKG:2659)

Hong Kong · Delayed Price · Currency is HKD

14.31

-0.59 (-3.96%)

Sep 11, 2026, 4:08 PM HKT

HKG:2659 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	17.04	49.16	6.16	6.93
Revenue Growth	-65.33%	697.99%	-11.11%	-
Gross Profit	11.36	43.75	5.02	6.78
Operating Income	-297.65	-309.04	-359.49	-166.66
Net Income	-365.89	-395.3	-364.43	-160.4
Earnings Per Share	-1.18	-1.36	-1.36	-0.63
EPS Growth	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Investments	1,044	1,243	525.33	324.13
Total Debt	423.17	315	205.26	111.12
Net Cash (Debt)	621.05	927.95	320.08	213.01
Net Cash Growth	-33.07%	189.91%	50.26%	-
Net Cash Per Share	2.01	3.20	1.20	0.84

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Cash Flow	-221.48	-180.05	-219.78	-140.21
Capital Expenditures	-250.72	-153.36	-118.27	-136.37
Free Cash Flow	-472.2	-333.41	-338.06	-276.58
Free Cash Flow Growth	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Gross Margin	66.69%	89.00%	81.49%	97.85%
Operating Margin	-1746.68%	-628.68%	-5835.80%	-2404.96%
Pretax Margin	-2147.12%	-804.18%	-5916.49%	-2314.52%
Profit Margin	-2147.12%	-804.18%	-5916.12%	-2314.50%
FCF Margin	-2770.96%	-678.27%	-5487.91%	-3991.02%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
PS Ratio	246.82	462.14	-	-